Evidence map›Paper›PMID 40561105›Full record

ReviewJournal of leukocyte biology2025

The role of liver macrophages in viral liver pathogenesis.

Alexis Brantly, Kyle Yeakle, Michael J Bouchard, Peter J Gaskill, Michael R Nonnemacher

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026
    Review
  2. Macrophages in oncoviral infections: from immune regulators to therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexis BrantlyMicrobiology and Immunology Graduate Program, Graduate School of Biomedical Sciences and Professional Studies, Drexel University College of Medicine, 245 N 15th St, Philadelphia, PA 19102, United States.
Kyle YeakleMolecular and Cell Biology and Genetics Graduate Program, Graduate School of Biomedical Sciences and Professional Studies, Drexel University College of Medicine, 245 N 15th St, Philadelphia, PA 19102, United States.
Michael J BouchardMolecular and Cell Biology and Genetics Graduate Program, Graduate School of Biomedical Sciences and Professional Studies, Drexel University College of Medicine, 245 N 15th St, Philadelphia, PA 19102, United States.
Peter J GaskillSidney Kimmel Cancer Center, Thomas Jefferson University, 833 Chestnut Street, Philadelphia, PA 19107, United States.
Michael R NonnemacherDepartment of Microbiology and Immunology, Drexel University College of Medicine, 245 N 15th St, Rm 18304, Philadelphia, PA 19102, United States.ORCID 0000-0003-4299-3779

Funding

HIV-1 Tat genetic variation impacts NeuroAIDSR01NS089435 · NINDS · DREXEL UNIVERSITY · PI KORTAGERE, SANDHYA, NONNEMACHER, MICHAEL R · 2015 to 2024
$5.0M
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populationsR01DA057337 · NIDA · DREXEL UNIVERSITY · PI Peter Jesse Gaskill, Zachary Alan Klase · 2022 to 2026
$3.4M
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIVR33DA058501 · NIDA · DREXEL UNIVERSITY · PI Peter Jesse Gaskill · 2025 to 2026
$1.4M
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIVR61DA058501 · NIDA · DREXEL UNIVERSITY · PI GASKILL, PETER JESSE · 2023 to 2024
$1.1M
HIV Tat and HBV HBx in HIV/HBV Coinfection-associated Liver DiseaseR21AI158024 · NIAID · DREXEL UNIVERSITY · PI BOUCHARD, MICHAEL J., NONNEMACHER, MICHAEL R · 2021 to 2022
$407k
Future self: An episodic future thinking intervention for comorbid tobacco use disorder and bipolar disorderK23DA058051 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GOLD, ALEXANDRA KATE · 2024 to 2025
$393k
NIAID NIH HHS R21 AI158024NIDA NIH HHS K23 DA058051NIDA NIH HHS R01 DA057337NIDA NIH HHS R33 DA058501NIDA NIH HHS R61 DA058501NIH HHS NIH-R01NS089435NIH HHS R01DA057337NIH HHS R21AI158024NIH HHS R61DA058051NINDS NIH HHS R01 NS089435
6 · The paper itself

Abstract

Liver macrophages play important roles in the pathophysiology of liver fibrosis and hepatocellular carcinoma. However, liver macrophages are a heterogenous population and have differing roles in maintenance of liver function and response in disease. In a healthy liver, macrophages play a critical role in antigen processing, maintaining tolerance to the high levels of gut-derived bacterial products, and regulating inflammation through cytokine response. However, macrophages also play a critical role in liver pathology, specifically in the context of viral infection. The liver is targeted by multiple viruses, including human immunodeficiency virus, hepatitis B virus, and hepatitis C virus, which dysregulate macrophage functions to affect liver disease. Infection with any of these viruses is associated with increased risk of developing hepatocellular carcinoma, and coinfection further accelerates the progression to liver disease and cancer. However, the exact mechanisms by which liver macrophages contribute to disease in the context of viral infections are not well defined. This is a particularly acute issue in human immunodeficiency virus-infected populations, which have high incidence of hepatitis B virus and hepatitis C virus coinfection. To address this knowledge gap, this review describes the populations of macrophages in the liver, outlines the current models and limitations associated with the study of liver macrophages, discusses the function and role of liver macrophages in the context of viral infection, and describes the mechanisms by which these cells contribute to hepatocellular carcinoma and fibrosis. We then use this information to propose focus areas for the liver macrophage field to better address and resolve viral liver disease.

Indexed as

LiverMacrophagesAnimalsCarcinoma, HepatocellularCoinfectionHepacivirusHepatitis BHepatitis B virusHepatitis CHIV InfectionsHumansLiver NeoplasmsHBVHCCHCVHIVmacrophage

Identifiers

PMID40561105
PMCPMC12400039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.